Literature DB >> 15007021

Digitalis administration: an underappreciated but common cause of short QT interval.

Tsung O Cheng.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 15007021     DOI： 10.1161/01.CIR.0000118177.56908.5B

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  9 in total

1.  DNA fragmentation in leukocytes following subacute low-dose nerve agent exposure.

Authors:  J R Moffett; R A Price; S M Anderson; M L Sipos; A V Moran; F C Tortella; J R Dave
Journal:  Cell Mol Life Sci       Date:  2003-10       Impact factor: 9.261

2.  Clinical relevance of the (S)-citalopram-omeprazole interaction in geriatric patients.

Authors:  Roberto Lozano; Clara Bibian; Raquel-Maria Quilez; Javier Gil; Yamile Constante; Ernesto Garcia-Arilla
Journal:  Br J Clin Pharmacol       Date:  2014-06       Impact factor: 4.335

3.  PQ segment depression in patients with short QT syndrome: a novel marker for diagnosing short QT syndrome?

Authors:  Erol Tülümen; Carla Giustetto; Christian Wolpert; Philippe Maury; Olli Anttonen; Vincent Probst; Jean-Jacques Blanc; Pascal Sbragia; Chiara Scrocco; Boris Rudic; Christian Veltmann; Yaxun Sun; Fiorenzo Gaita; Charles Antzelevitch; Martin Borggrefe; Rainer Schimpf
Journal:  Heart Rhythm       Date:  2014-02-28       Impact factor: 6.343

Review 4.  Channelopathies: Brugada syndrome, long QT syndrome, short QT syndrome, and CPVT.

Authors:  Rainer Schimpf; Christian Veltmann; Christian Wolpert; Martin Borggrefe
Journal:  Herz       Date:  2009-06       Impact factor: 1.443

5.  Assessment of QT intervals and prevalence of short QT syndrome in Japan.

Authors:  Akira Funada; Kenshi Hayashi; Hidekazu Ino; Noboru Fujino; Katsuharu Uchiyama; Kenji Sakata; Eiichi Masuta; Yuichiro Sakamoto; Toshinari Tsubokawa; Masakazu Yamagishi
Journal:  Clin Cardiol       Date:  2008-06       Impact factor: 2.882

6.  Therapeutic effects of a taurine-magnesium coordination compound on experimental models of type 2 short QT syndrome.

Authors:  Meng-Yao An; Kai Sun; Yan Li; Ying-Ying Pan; Yong-Qiang Yin; Yi Kang; Tao Sun; Hong Wu; Wei-Zhen Gao; Jian-Shi Lou
Journal:  Acta Pharmacol Sin       Date:  2017-10-26       Impact factor: 6.150

7.  Congenital short QT syndrome.

Authors:  Charles Antzelevitch; Johnson Francis
Journal:  Indian Pacing Electrophysiol J       Date:  2004-04-01

8.  Molecular Insights into the Short QT Syndrome.

Authors:  Srikanth Perike; Mark D McCAULEY
Journal:  J Innov Card Rhythm Manag       Date:  2018-03

9.  Comprehensive in vitro pro-arrhythmic assays demonstrate that omecamtiv mecarbil has low pro-arrhythmic risk.

Authors:  Yusheng Qu; BaoXi Gao; Ziva Arimura; Mei Fang; Hugo M Vargas
Journal:  Clin Transl Sci       Date:  2021-05-05       Impact factor: 4.689
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.